aggressive breast cancer

Keytruda Extends Survival for Women With an Aggressive Breast Cancer

by
Keytruda Extends Survival for Women With an Aggressive Breast Cancer

By Amy Norton HealthDay Reporter THURSDAY, July 21, 2022 (HealthDay News) — Adding the drug Keytruda to standard chemotherapy can extend the lives of some women with an aggressive form of breast cancer, a new study finds. The study involved women with advanced triple-negative breast cancer, a hard-to-treat form of the disease. Keytruda (pembrolizumab) is … Read more

New Drug Combo Boosts Survival Against Aggressive Form of Breast Cancer

by
New Drug Combo Boosts Survival Against Aggressive Form of Breast Cancer

By Denise Mann HealthDay Reporter MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1). … Read more